All Stories

  1. Physical activity promotion in the community pharmacy: An opportunity for an expanded role?
  2. Pharmacists’ involvement in physical activity promotion in community pharmacy: a systematic review
  3. Effects of inpatient creatinine testing frequency on acute kidney injury identification and staging: a historical cohort study
  4. Impact of harm minimization interventions on reducing blood-borne infection transmission and some injecting behaviors among people who inject drugs: an overview and evidence gap mapping
  5. Real-world effectiveness of aromatase inhibitors and fulvestrant in HR+/HER2- advanced breast cancer: a snapshot of the last two years before conventional use of CDK 4/6 inhibitors in a Portuguese institution
  6. Relationship of the SITLESS intervention on medication use in community-dwelling older adults: an exploratory study
  7. Overview of this issue: “clinical pharmacy impacting mental health delivery and outcomes”
  8. Clinical pharmacy services in mental health in Europe: a commentary paper of the European Society of Clinical Pharmacy Special Interest Group on Mental Health
  9. Effectiveness of palbociclib with aromatase inhibitors for the treatment of advanced breast cancer in an exposure retrospective cohort study: implications for clinical practice
  10. International validation of two EORTC questionnaires for assessment of health‐related quality of life for patients with high‐grade non‐Hodgkin lymphoma (QLQ‐NHL‐HG29) and low‐grade non‐Hodgkin lymphoma (QLQ‐NHL‐LG20)
  11. Epidemiological and clinical characterization of a population-based cohort of cutaneous malignant melanoma patients in the South Region of Portugal
  12. Translation and cross-cultural adaptation of the ABC taxonomy for medication adherence into Portuguese – Updating patients into people
  13. Evidence of the Impact of Harm Minimization Programs
  14. Perceptions of European students' representative associations about clinical pharmacy undergraduate education
  15. Cancer care for Ukrainian refugees: Strategic impact assessments in the early days of the conflict
  16. Editorial: Women in drugs outcomes research and policies: 2021
  17. National trends in the use of oral chemotherapy over 13 years
  18. Healthcare Professionals' Views on the Management of Medication Complexities in the Elderly With Mental Health Disorders: A Cross-Sectional Study
  19. The WHO Prison Health Framework: a framework for assessment of prison health system performance
  20. Real-world effectiveness of palbociclib plus fulvestrant in advanced breast cancer: Results from a population-based cohort study
  21. Estarão os Doentes com Fibrilhação Auricular Correctamente Anticoagulados? Um Retrato de um Hospital Português do Interior
  22. Protocolo de Atuação Rápida da Dor Torácica Aguda: Experiência Obtida num Hospital do Alentejo
  23. Success in Vaccination Efforts of Vulnerable Populations in the WHO/European Region: Focus on Prisons
  24. Auditing the scope of antithrombotic care in iPACT (International Pharmacists for Anticoagulation Care Taskforce) represented countries
  25. Universal health coverage for mental health: the contribution of clinical pharmacists
  26. A cross-sectional survey to map Clinical Pharmacy Education and Practice in Europe
  27. Pharmacists’ involvement in COVID-19 vaccination across Europe: a situational analysis of current practice and policy
  28. Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study
  29. Response measures to COVID-19 in prisons and other detention centers
  30. Editorial
  31. Prisons need to be included in global and national vaccinations effort against COVID-19
  32. Accessing the potential impact of education about cancer screening programs: a pilot before and after study
  33. Management of clinical relevant drug-drug interactions with antipsychotics in nursing homes
  34. Mapping Clinical Pharmacy Education and Practice in Europe
  35. An overview of Portugal's educational challenges and responses to the global pandemic of COVID-19
  36. Building the Pharmacy Workforce of Tomorrow
  37. Relationships Between Academia and Professionals
  38. Monitoring real‐life utilization of pembrolizumab in advanced melanoma using the Portuguese National Cancer Registry
  39. Identification of a Set of Patient-Related Features to Foster Safe Prescribing of Specific Antipsychotics in the Elderly With Dementia
  40. Awareness about barriers to medication adherence in cardiovascular patients and strategies used in clinical practice by Portuguese clinicians: a nationwide study
  41. Prevention and Control of COVID-19 in Italian Prisons: Stringent Measures and Unintended Consequences
  42. Real‐world effectiveness of pembrolizumab in previously treated non‐small cell lung cancer: A population‐based cohort study
  43. Impact of a global leader on pharmaceutical practice and policy around the world
  44. Foppe van Mil (1950–2020)
  45. Today the pharmacy world lost a leader in pharmaceutical care
  46. Community pharmacist-led medication review procedures across Europe: Characterization, implementation and remuneration
  47. Primary health care policy and vision for community pharmacy and pharmacists in Portugal
  48. Pharmacists reinventing their roles to effectively respond to COVID-19: a global report from the international pharmacists for anticoagulation care taskforce (iPACT)
  49. Contribution of Different Patient Information Sources to Create the Best Possible Medication History
  50. The association between receptor binding affinity and metabolic side effect profile of antipsychotics and major cardio- and cerebrovascular events: A case/non-case study using VigiBase
  51. Raising awareness and early detection of atrial fibrillation, an experience resorting to mobile technology centred on informed individuals
  52. The patient pathway in cardiovascular care: A position paper from the International Pharmacists for Anticoagulation Care Taskforce (iPACT)
  53. Development of a Platform to Align Education and Practice: Bridging Academia and the Profession in Portugal
  54. Febrile Neutropenia in Patients with Solid Tumors Undergoing Intravenous Chemotherapy
  55. Using cancer registries to supplement clinical trial data and inform regulatory decision
  56. Awareness campaigns of atrial fibrillation as an opportunity for early detection by pharmacists: an international cross-sectional study
  57. Creating an Interprofessional guideline to support patients receiving oral anticoagulation therapy: a Delphi exercise
  58. Elderly use of medication with potential cardiovascular risks
  59. Potentially inappropriate medications with risk of cardiovascular adverse events in the elderly: A systematic review of tools addressing inappropriate prescribing
  60. Management and 1‐Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD‐AF Registry
  61. Existing pharmacy services in Europe: availability for the public and payments for service providers
  62. The cancer registry as an ally in monitoring treatment effectiveness
  63. The South Region Cancer Registry: an evaluation of its exhaustiveness in a cohort of lung cancer patients
  64. Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry
  65. The social value of pharmaceutical interventions, the Portuguese contribution to sustainable development
  66. Using a cancer registry to capture signals of adverse events following immune and targeted therapy for melanoma
  67. Correction to: Pharmacists’ confidence when providing pharmaceutical care on anticoagulants, a multinational survey
  68. Pharmacists’ confidence when providing pharmaceutical care on anticoagulants, a multinational survey
  69. How prepared are pharmacists to support atrial fibrillation patients in adhering to newly prescribed oral anticoagulants?
  70. Optimising patient safety using pharmaceutical intervention in domiciliary hospitalization
  71. Provision of pharmaceutical care by community pharmacists across Europe: Is it developing and spreading?
  72. 45th ESCP-NSF international symposium on clinical pharmacy: clinical pharmacy tackling inequalities and access to health care. Oslo, Norway, 5–7 October 2016
  73. Effects of economic recession on elderly patients’ perceptions of access to health care and medicines in Portugal
  74. Sexual Dysfunction in Breast Cancer Survivors: Cross-Cultural Adaptation of the Sexual Activity Questionnaire for Use in Portugal
  75. Potentially inappropriate medications in a sample of Portuguese nursing home residents: Does the choice of screening tools matter?
  76. Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD-AF and treated with vitamin K antagonists
  77. Determinants of self-medication with NSAIDs in a Portuguese community pharmacy
  78. Drug-Related Problems Identified in a Sample of Portuguese Institutionalised Elderly Patients and Pharmacists’ Interventions to Improve Safety and Effectiveness of Medicines
  79. The organizational framework of community pharmacies in Europe
  80. Primary non-adherence in Portugal: findings and implications
  81. Does Sex Affect Anticoagulant Use for Stroke Prevention in Nonvalvular Atrial Fibrillation?: The Prospective Global Anticoagulant Registry in the FIELD-Atrial Fibrillation
  82. Evaluation of Antibiotic Prescription for Upper Respiratory Tract Infections in the Community Pharmacy Setting
  83. Impact of pharmaceutical counseling in minor health problems in rural Portugal
  84. Effect of Darapladib on Major Coronary Events After an Acute Coronary Syndrome
  85. Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
  86. Provision of pharmaceutical care by community pharmacists: a comparison across Europe
  87. Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: The ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention)
  88. Monitoring quality standards in the provision of non-prescription medicines from Australian Community Pharmacies: results of a national programme
  89. Effect of reminder cards on compliance with antihypertensive medication
  90. Assessing the pharmaceutical care needs of asthmatic patients
  91. Documentation forms for patients with asthma: an evaluation